BiotechSwings
Approvals already landed this morning and the week is just starting
Sanofi venglustat got approved today, ahead of its Nov 25 date, the first US therapy aimed at the neurological side of type 3 Gaucher. Regeneron cemdisiran was approved today too
today also has data, $BHVN Phase 1 on BHV 1530 and Immutep efti
the next 7 days stack up fast
Nov 22 $CAPR deramiocel PDUFA, a Sunday date so Friday is the practical window
Nov 22 $SVRA Molbreevi PDUFA, same Sunday setup
Nov 27 BridgeBio BBP 418 PDUFA right behind them
1
4
